The aim is to explore how SHED-derived exosomes can alleviate age-related osteoporosis by enhancing mitophagy in senescent bone marrow mesenchymal stem cells (BMSCs).
Utilized SHED-exosomes from stem cells.
Investigated their impact on senescent BMSCs.
Measured effects on mitophagy activation and bone health.
SHED-exosomes significantly activated mitophagy in senescent BMSCs.
There was noted improvement in markers of age-related osteoporosis.
Potential for SHED-exosomes as a treatment for bone disorders in older populations.
Abstract
SHED-Exo ameliorate age-related OP by activating mitophagy in senescent BMSCs, serving as a novel translational nanotherapeutic for age-related bone disorders.